4.6 Letter

Novel GNAL Mutations in Two German Patients With Sporadic Dystonia

期刊

MOVEMENT DISORDERS
卷 29, 期 14, 页码 1833-1834

出版社

WILEY-BLACKWELL
DOI: 10.1002/mds.26066

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Genetics & Heredity

MRM2 variants in families with complex dystonic syndromes: evidence for phenotypic heterogeneity

Anum Shafique, Beenish Arif, Mary Lynn Chu, Ellen Moran, Tooba Hussain, Francisca Millan Zamora, Elizabeth Wohler, Nara Sobreira, Christine Klein, Katja Lohmann, Sadaf Naz

Summary: This study investigated patients with dystonic or involuntary movement disorders in two families. Genetic analyses revealed mutations in the MRM2 gene that were associated with the phenotypes.

JOURNAL OF MEDICAL GENETICS (2023)

Article Clinical Neurology

Basal Ganglia Atrophy as a Marker for Prodromal X-Linked Dystonia-Parkinsonism

Henrike Hanssen, Cid C. E. Diesta, Marcus Heldmann, Jackson Dy, Jeffrey Tantianpact, Julia Steinhardt, Rosanna Sauza, Hans T. S. Manalo, Andreas Sprenger, Charles Jourdan Reyes, Raphael Tuazon, Bjoern-Hergen Laabs, Aloysius Domingo, Raymond L. Rosales, Christine Klein, Thomas F. Muente, Ana Westenberger, Jean Q. Oropilla, Norbert Brueggemann

Summary: In this study, it was found that X-linked dystonia-parkinsonism has basal ganglia atrophy and iron accumulation before the clinical onset. These findings highlight the potential of early diagnosis and the importance of understanding the prodromal phase of the disease.

ANNALS OF NEUROLOGY (2023)

Article Clinical Neurology

Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson's disease

Joanne Trinh, Andrew A. Hicks, Inke R. Koenig, Sylvie Delcambre, Theresa Lueth, Susen Schaake, Kobi Wasner, Jenny Ghelfi, Max Borsche, Carles Vilarino-Gueell, Faycel Hentati, Elisabeth L. Germer, Peter Bauer, Masashi Takanashi, Vladimir Kostic, Anthony E. Lang, Norbert Brueggemann, Peter P. Pramstaller, Irene Pichler, Alex Rajput, Nobutaka Hattori, Matthew J. Farrer, Katja Lohmann, Hansi Weissensteiner, Patrick May, Christine Klein, Anne Gruenewald

Summary: Trinh et al. found that PINK1/PRKN mutations increase the risk of mitochondrial DNA variant accumulation in a dose- and disease-dependent manner. Monoallelic mutation carriers can be distinguished by the level of heteroplasmic mtDNA variants. Biallelic mutations in PINK1/PRKN lead to recessive Parkinson's disease.
Letter Genetics & Heredity

A novel biallelic nonsense variant in SLC38A3 causing epileptic encephalopathy in an Indian family

Salem Alawbathani, Suliman Khan, Ana Westenberger, Christian Beetz, Lokesh Lingappa

CLINICAL GENETICS (2023)

Article Biochemistry & Molecular Biology

Participant perspective on the recall-by-genotype research approach: a mixed-method embedded study with participants of the CHRIS study

Roberta Biasiotto, Maria Koesters, Katharina Tschigg, Peter P. Pramstaller, Norbert Brueggemann, Max Borsche, Christine Klein, Andrew A. Hicks, Deborah Mascalzoni

Summary: Recall-by-genotype (RbG) research involves recalling participants based on their genotype, potentially leading to disclosure of unwanted genetic information. A study on participant views and preferences regarding RbG research approach provides valuable insights for RbG policy development.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Clinical Neurology

In Vivo Investigation of Glucose Metabolism in Idiopathic and PRKN-Related Parkinson's Disease

Max Borsche, Andre Maertens, Philipp Hoermann, Theresa Brueckmann, Katja Lohmann, Sinem Tunc, Christine Klein, Karsten Hiller, Alexander Balck

Summary: This study investigates the differences in glucose metabolism between Parkinson's disease (PD) patients and healthy controls using advanced biochemical methods. The results show that glucose production pathways differ between idiopathic and PRKN mutation carriers, and are associated with diabetes. This study provides the first in vivo evidence for alterations in glucose metabolism in idiopathic PD.

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Spectrum of Pediatric to Early Adulthood POLR3A-Associated Movement Disorders

Alonso Zea Vera, Adrienne Bruce, Travis R. Larsh, Zachary Jordan, Norbert Bruggemann, Ana Westenberger, Alberto J. Espay, Donald L. Gilbert, Steve W. Wu

Summary: POLR3A-related disorders exhibit significant phenotypic pleomorphism, including a range of movement disorders such as parkinsonism, dystonia, ataxia, and spasticity. Vertical gaze dysfunction and T2-weighted/FLAIR hyperintensity of the superior cerebellar peduncles and midbrain may be useful signs suggestive of this condition.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Biochemistry & Molecular Biology

Role of Ceramides and Sphingolipids in Parkinson's Disease

Melissa Vos, Christine Klein, Andrew A. Hicks

Summary: Sphingolipids, a subset of bioactive lipids, play a crucial role in proper neuronal function and are involved in almost all biological processes. Recent studies have found alterations in sphingolipids in patients with Parkinson's disease (PD), suggesting an important interaction between sphingolipids and PD-related cellular processes. This article discusses the role of sphingolipids in mitochondrial dysfunction, autophagy defects, and abnormal endosomal activity in PD.

JOURNAL OF MOLECULAR BIOLOGY (2023)

Article Clinical Neurology

Oculomotor abnormalities indicate early executive dysfunction in prodromal X-linked dystonia-parkinsonism (XDP)

Renana Mertin, Cid Diesta, Norbert Brueggemann, Raymond L. L. Rosales, Henrike Hanssen, Ana Westenberger, Julia Steinhardt, Marcus Heldmann, Hans T. S. Manalo, Jean Q. Q. Oropilla, Christine Klein, Christoph Helmchen, Andreas Sprenger

Summary: This study investigated oculomotor behavior in non-manifesting mutation carriers (NMC) of X-linked dystonia-parkinsonism (XDP). The findings showed that NMC already displayed some oculomotor deficits similar to XDP patients, indicating striatal and prefrontal impairment. It is suggested that neurodegeneration may commence in the striatum and prefrontal cortex of XDP patients.

JOURNAL OF NEUROLOGY (2023)

Letter Clinical Neurology

The New p.F1700L LRRK2 Variant Causes Parkinson's Disease by Extensively Increasing Kinase Activity

Max Borsche, Neringa Pratuseviciute, Susen Schaake, Frauke Hinrichs, Gabriel Morel, Jan Uter, Katja Lohmann, Christine Klein, Dario R. Alessi, Johann Hagenah, Esther Sammler

MOVEMENT DISORDERS (2023)

Letter Clinical Neurology

Spectrum of FAR1 (Fatty Acyl-CoA Reductase 1) Variants and Related Neurological Conditions

Ana Westenberger, Adriana Ruiz-Herrera, Sevcan Bozdogan, Atil Bisgin, Mohammed Almuqbil, Amal Alhashem, Talal Alanzi, Antonio Romito, Arndt Rolfs, Patricia Dias, Raquel Gouveia Silva, Aida M. Bertoli-Avella, Peter Bauer, Christian Beetz

MOVEMENT DISORDERS (2023)

Letter Clinical Neurology

Shaking Up Ataxia: FGF14 and RFC1 Repeat Expansions in Affected and Unaffected Members of a Chilean Family

Paula Saffie Awad, Katja Lohmann, Yasmin Hirmas, Frauke Hinrichs, Mirja Thomsen, Marcelo Kauffman, Theresa Lueth, Joanne Trinh, Ana Westenberger, Pedro Chana-Cuevas, Christine Klein

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Tremor is associated with familial clustering of dystonia

Sebastian Loens, Feline Hamami, Katja Lohmann, Thorsten Odorfer, Chi Wang Ip, Simone Zittel, Kirsten E. Zeuner, Judith Everding, Jos Becktepe, Katrin Marth, Friederike Borngraeber, Katja Kollewe, Christoph Kamm, Andrea A. Kuehn, Mathias Gelderblom, Jens Volkmann, Christine Klein, Tobias Baeumer

Summary: This study aims to identify clinical and demographic features associated with heritability of yet idiopathic dystonia. Tremor is associated with an increased risk of familial clustering of dystonia and with a family history of tremor itself. This indicates a hereditable dystonia-tremor syndrome with a clinical spectrum ranging from tremor-predominant diseases to dystonia.

PARKINSONISM & RELATED DISORDERS (2023)

Article Cell & Tissue Engineering

p Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson?s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p. T610A) in the RHOT1 gene encoding Miro1

Axel Chemla, Giuseppe Arena, Claudia Saraiva, Clara Berenguer-Escuder, Dajana Grossmann, Anne Grunewald, Christine Klein, Philip Seibler, Jens C. Schwamborn, Rejko Kruger

Summary: In this study, two Parkinson's disease patients' primary skin fibroblasts carrying distinct heterozygous mutations in the RHOT1 gene encoding Miro1 were reprogrammed into induced pluripotent stem cells (iPSCs) using episomal reprogramming. Isogenic gene-corrected lines were generated using CRISPR/Cas9 technology. Both isogenic pairs were comprehensively characterized and quality assured to study the Miro1-related molecular mechanisms underlying neurodegeneration in iPSC-derived neuronal models.

STEM CELL RESEARCH (2023)

Article Clinical Neurology

A Network Imaging Biomarker of X-Linked Dystonia-Parkinsonism

Martin Niethammer, Chris C. C. Tang, Roland Dominic G. Jamora, An Vo, Nha Nguyen, Yilong Ma, Shichun Peng, Jeff L. Waugh, Ana Westenberger, David Eidelberg

Summary: The objective of this study was to characterize a metabolic brain network associated with X-linked dystonia-parkinsonism (XDP). PET scans were conducted on Filipino men with XDP and healthy men without the condition. The results showed that XDP is associated with abnormal functional connectivity in the brain.

ANNALS OF NEUROLOGY (2023)

暂无数据